Valentis and Eurogene restenosis deal

VLTS and Eurogene (London, U.K.) will develop a Nitric Oxide Synthase (eNOS) gene therapy to prevent and treat restenosis following bypass graft surgery. The product will combine VLTS's gene formulati...